Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
AstraZeneca
Medtronic
McKinsey
Colorcon

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,811,254

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,811,254 protect, and when does it expire?

Patent 7,811,254 protects ALSUMA and is included in one NDA.

This patent has four patent family members in four countries.

Summary for Patent: 7,811,254
Title:Autoinjector with needle depth adapter
Abstract:An autoinjector useful for, inter alia, providing an injection of liquid medicament is disclosed, which includes a needle depth adapter for achieving a desired injection depth.
Inventor(s): Wilmot; John G. (Mount Airy, MD), Hill; Robert L. (Abingdon, MD)
Assignee: Meridian Medical Technologies, Inc. (Columbia, MD)
Application Number:11/788,823
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Use;

Drugs Protected by US Patent 7,811,254

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Meridian Medcl ALSUMA sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022377-001 Jun 29, 2010 DISCN No No   Start Trial   Start Trial Y ACUTE TREATMENT OF MIGRAINE ATTACKS, WITH OR WITHOUT AURA, AND THE TREATMENT OF CLUSTER HEADACHE EPISODES   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,811,254

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2666860   Start Trial
European Patent Office 2073866   Start Trial
Taiwan 200838574   Start Trial
World Intellectual Property Organization (WIPO) 2008048750   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Colorcon
Baxter
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.